However, a systematic explanation of the clinical application and diagnostic value of IGF2BP3 in breast cancer has not been achieved, mainly due to limited sample sizes in some studies or insufficient comprehensive clinicopathological correlation analyses. This evidence concerns the gene IGF2BP3 and breast cancer.